Key Segmentation:
By Type
-
Live-Attenuated
-
Inactivated
-
Subunit
-
mRNA
-
Viral Vector
-
Conjugate
-
Others
By Administration Route
-
Intramuscular
-
Subcutaneous
-
Oral
-
Intradermal
By Disease Target
-
COVID-19
-
Influenza
-
Hepatitis
-
Measles
-
Polio
-
HPV
-
Others
By Age Group
-
Pediatrics
-
Adolescent
-
Adult
-
Geriatrics
By End User
-
Hospitals
-
Clinics
-
Research & Academic Institutes
-
Others
By Distribution Channel
-
Hospital Pharmacy
-
Retail Pharmacy
-
Online Pharmacy
-
Government Programs
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: North America dominated the market with a 34.56% share in 2025, while Asia-Pacific is the fastest-growing region with a CAGR of 5.89% during 2026–2035.
Inactivated vaccines dominated with a 28.74% share in 2025, while mRNA vaccines are projected to record the fastest growth with a 7.12% CAGR during 2026–2035.
Growth is driven by rising infectious diseases, expanding immunization programs, increasing vaccine awareness and rapid advancements in mRNA and viral vector technologies.
The market is valued at USD 44.26 Billion in 2025 and is projected to reach USD 68.28 Billion by 2035.
The Human Vaccines Market is expected to grow at a CAGR of 4.43% during the forecast period 2026–2035.